{
 "name": "永笙-KY",
 "slug": "tw-4178",
 "aliases": [
  "永笙生技股份有限公司",
  "StemCyte",
  "4178"
 ],
 "ticker": "4178",
 "industry": "生技醫療業",
 "website": "https://stemcytebio.com/",
 "summary": "永笙-KY（4178）是上市的生技醫療類股公司，2013 年成立，2026 年上市。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "永笙生技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "英文簡稱",
   "value": "StemCyte",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "掛牌市場",
   "value": "臺灣證券交易所上市",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "上市日期",
   "value": "2026-04-30",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "成立日期",
   "value": "2013-06-26",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "董事長",
   "value": "王嘉宗",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "總經理",
   "value": "路孔明",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "實收資本額",
   "value": 2159053150,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "勤業眾信會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "公司網址",
   "value": "https://stemcytebio.com/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 30711,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": 28.21,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": 2.71,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L"
  },
  {
   "claim": "產品許可：REGENECYTE（HPC, Cord Blood）",
   "value": "FDA BLA STN 125764／U.S. License 2280｜美國｜2024-11-20",
   "unit": "",
   "as_of": "2024-11-20",
   "source": "https://www.fda.gov/media/183774/download?attachment",
   "note": "FDA BLA核准函；核准為非親屬造血前驅細胞移植搭配適當預處理之造血與免疫重建，非長新冠／中風／腦性麻痺已獲上市許可。"
  },
  {
   "claim": "管線：REGENECYTE（HPC, Cord Blood；台灣查驗登記）",
   "value": "造血及免疫系統重建｜已向TFDA申請再生醫療製劑查驗登記（NDA）｜台灣",
   "unit": "",
   "as_of": "2026-09-30",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?seq_no=1&spoke_time=185257&spoke_date=20260930&co_id=4178&TYPEK=sii&step=2&firstin=1&encodeURIComponent=1",
   "note": "發言日期：2026-09-30 18:52:57；主旨：代重要子公司StemCyte,Inc.(美國永生公司)公告向臺灣衛生福利部食品藥物管理署申請臍帶血細胞製劑REGENECYTE再生醫療製劑查驗登記(NDA)。尚未核准；公告明述實際核准時間及准駁為食藥署職權，不填催化劑核准日。"
  },
  {
   "claim": "管線：REGENECYTE（HPC, Cord Blood；長新冠二a期）",
   "value": "長新冠症候群｜二a期試驗已完成（COMPLETED）｜美國",
   "unit": "",
   "as_of": "2025-03-24",
   "source": "https://clinicaltrials.gov/study/NCT05682560",
   "note": "NCT05682560；as_of為Last Update Posted（登錄公開更新日），狀態僅按該次官方登錄。無試驗地區欄者不以聯絡人地址或申辦者國籍代填。"
  },
  {
   "claim": "管線：REGENECYTE（HPC, Cord Blood；長新冠三期）",
   "value": "長新冠症候群｜三期；登錄狀態尚未招募（NOT_YET_RECRUITING）｜試驗地區未登錄",
   "unit": "",
   "as_of": "2025-09-23",
   "source": "https://clinicaltrials.gov/study/NCT07184385",
   "note": "NCT07184385；as_of為Last Update Posted（登錄公開更新日），狀態僅按該次官方登錄。無試驗地區欄者不以聯絡人地址或申辦者國籍代填。"
  },
  {
   "claim": "管線：hUCB（急性缺血性中風）",
   "value": "急性缺血性中風｜二期；登錄狀態尚未招募（NOT_YET_RECRUITING）｜試驗地區未登錄",
   "unit": "",
   "as_of": "2025-02-27",
   "source": "https://clinicaltrials.gov/study/NCT06040476",
   "note": "NCT06040476；as_of為Last Update Posted（登錄公開更新日），狀態僅按該次官方登錄。無試驗地區欄者不以聯絡人地址或申辦者國籍代填。"
  },
  {
   "claim": "管線：hUCB（腦性麻痺）",
   "value": "腦性麻痺｜一期；登錄狀態尚未招募（NOT_YET_RECRUITING）｜試驗地區未登錄",
   "unit": "",
   "as_of": "2025-02-27",
   "source": "https://clinicaltrials.gov/study/NCT06377982",
   "note": "NCT06377982；as_of為Last Update Posted（登錄公開更新日），狀態僅按該次官方登錄。無試驗地區欄者不以聯絡人地址或申辦者國籍代填。"
  },
  {
   "claim": "管線：MC001（臍帶血單核細胞）",
   "value": "脊髓損傷｜二期已終止（TERMINATED；商業策略考量）｜台灣",
   "unit": "",
   "as_of": "2025-02-28",
   "source": "https://clinicaltrials.gov/study/NCT03979742",
   "note": "NCT03979742；as_of為Last Update Posted（登錄公開更新日），狀態僅按該次官方登錄。無試驗地區欄者不以聯絡人地址或申辦者國籍代填。"
  },
  {
   "claim": "管線：REGENECYTE（長新冠擴大使用）",
   "value": "長新冠之慢性疲勞｜擴大使用計畫可提供（AVAILABLE；非新適應症上市核准）｜美國",
   "unit": "",
   "as_of": "2026-03-23",
   "source": "https://clinicaltrials.gov/study/NCT07332338",
   "note": "NCT07332338；as_of為Last Update Posted（登錄公開更新日），狀態僅按該次官方登錄。無試驗地區欄者不以聯絡人地址或申辦者國籍代填。"
  },
  {
   "claim": "催化劑：NCT07184385",
   "value": "長新冠三期試驗預估主要完成日｜2027-06-30（登錄預估）｜已公告",
   "unit": "",
   "as_of": "2025-09-23",
   "source": "https://clinicaltrials.gov/study/NCT07184385",
   "note": "NCT07184385；ClinicalTrials.gov由申辦者登錄的ESTIMATED時程，非主管機關承諾，亦非試驗結果發表日；登錄仍顯示尚未招募，時程可能變更，未自行判作延後。"
  },
  {
   "claim": "催化劑：NCT07184385",
   "value": "長新冠三期試驗預估研究完成日｜2027-09-30（登錄預估）｜已公告",
   "unit": "",
   "as_of": "2025-09-23",
   "source": "https://clinicaltrials.gov/study/NCT07184385",
   "note": "NCT07184385；ClinicalTrials.gov由申辦者登錄的ESTIMATED時程，非主管機關承諾，亦非試驗結果發表日；登錄仍顯示尚未招募，時程可能變更，未自行判作延後。"
  },
  {
   "claim": "催化劑：NCT06040476",
   "value": "急性缺血性中風二期試驗預估主要完成月份｜2027-12（登錄預估）｜已公告",
   "unit": "",
   "as_of": "2025-02-27",
   "source": "https://clinicaltrials.gov/study/NCT06040476",
   "note": "NCT06040476；ClinicalTrials.gov由申辦者登錄的ESTIMATED時程，非主管機關承諾，亦非試驗結果發表日；登錄仍顯示尚未招募，時程可能變更，未自行判作延後。"
  },
  {
   "claim": "催化劑：NCT06377982",
   "value": "腦性麻痺一期試驗預估主要完成月份｜2027-09（登錄預估）｜已公告",
   "unit": "",
   "as_of": "2025-02-27",
   "source": "https://clinicaltrials.gov/study/NCT06377982",
   "note": "NCT06377982；ClinicalTrials.gov由申辦者登錄的ESTIMATED時程，非主管機關承諾，亦非試驗結果發表日；登錄仍顯示尚未招募，時程可能變更，未自行判作延後。"
  }
 ],
 "provided_by": "public_sources",
 "verified_at": "2026-10-22",
 "url": "https://drugnews.com.tw/companies/tw-4178.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}